DESIRE or Developing and Evaluating Short-acting Innovations for Rectal Use is an open-label crossover study to systematically examine multiple placebo methods for delivering drugs to help prevent HIV from anal sex. The study will include approximately 210 HIV-negative cisgender men, transgender men and transgender women who have sex with men at multiple locations around the world including UAB. For more information please contact 205-996-4405.